FCF YoY
+14.27%
OCF YoY
+0.36%
Capex YoY
-88.71%
FCF Conversion Δ
+12.3 pp
Free cash flow bridge for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $327.60M
FCF bridge breakdown for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $2.30B | — |
| Operating Cash Flow | $9.30M | +2.8% |
| Capital Expenditure | $318.30M | +97.2% |
| Free Cash Flow | $2.62B | — |
- Prior Free Cash Flow$2.30B
- Operating Cash Flow$9.30M
- Capital Expenditure$318.30M
- Free Cash Flow$2.62B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement